Alumis Inc (ALMS)

$12.5

-0.01

(-0.08%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $12.35
    $12.98
    $12.50
    downward going graph

    1.2%

    Downside

    Day's Volatility :4.85%

    Upside

    3.7%

    downward going graph
  • $10.45
    $13.53
    $12.50
    downward going graph

    16.4%

    Downside

    52 Weeks Volatility :22.76%

    Upside

    7.61%

    downward going graph

Returns

PeriodAlumis IncIndex (Russel 2000)
3 Months
-6.02%
0.0%
6 Months
-6.02%
0.0%
1 Year
-6.02%
0.0%
3 Years
-6.02%
-19.4%

Highlights

Market Capitalization
614.1M
Book Value
- $30.81
Earnings Per Share (EPS)
-3.26
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
0.0%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-167.2M
Diluted Eps TTM
-3.26
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Technicals Summary

Sell

Neutral

Buy

Alumis Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Alumis Inc
Alumis Inc
-6.02%
-6.02%
-6.02%
-6.02%
-6.02%
Moderna, Inc.
Moderna, Inc.
-9.87%
21.5%
-2.91%
-60.58%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
1.84%
12.81%
47.11%
81.12%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-6.7%
24.69%
59.95%
200.63%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.28%
11.69%
35.86%
150.1%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Alumis Inc
Alumis Inc
NA
NA
NA
0.0
0.0
0.0
NA
-30.81
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Alumis Inc
Alumis Inc
NA
$614.1M
-6.02%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Company Information

Organization
Alumis Inc
Employees
107
CEO
Industry
Miscellaneous

FAQs